ProShares Trust. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & Co.LLY | 12.67% | $9.13M | 8,263 |
| ProShares GENIUS Money Market ETFOther | 11.81% | $8.51M | 85,000 |
| Johnson & JohnsonJNJ | 7.86% | $5.66M | 25,129 |
| AbbVie, Inc.ABBV | 5.57% | $4.01M | 18,435 |
| UnitedHealth Group, Inc.UNH | 4.98% | $3.59M | 9,446 |
| Merck & Co., Inc.MRK | 4.26% | $3.07M | 25,881 |
| Repurchase AgreementRA | 2.91% | $2.10M | 2,096,800 |
| Thermo Fisher Scientific, Inc.TMO | 2.68% | $1.93M | 3,918 |
| Amgen, Inc.AMGN | 2.62% | $1.89M | 5,616 |
| Gilead Sciences, Inc.GILD | 2.41% | $1.74M | 12,937 |
| Intuitive Surgical, Inc.ISRG | 2.18% | $1.57M | 3,704 |
| Pfizer, Inc.PFE | 2.15% | $1.55M | 59,288 |
| Abbott LaboratoriesABT | 2.15% | $1.55M | 18,132 |
| Repurchase AgreementRA | 1.83% | $1.32M | 1,319,497 |
| Bristol-Myers Squibb Co.BMY | 1.68% | $1.21M | 21,228 |
| CVS Health Corp.CVS | 1.67% | $1.21M | 13,266 |
| Danaher Corp.DHR | 1.66% | $1.20M | 6,560 |
| Vertex Pharmaceuticals, Inc.VRTX | 1.64% | $1.19M | 2,649 |
| Stryker Corp.SYK | 1.52% | $1.10M | 3,593 |
| Repurchase AgreementRA | 1.37% | $989.62K | 989,622 |
| Medtronic plc | 1.37% | $986.84K | 13,370 |
| McKesson Corp.MCK | 1.32% | $948.10K | 1,277 |
| Elevance Health, Inc.ELV | 1.26% | $904.73K | 2,301 |
| Cigna Group (The)CI | 1.06% | $762.02K | 2,747 |
| Boston Scientific Corp.BSX | 1.04% | $747.07K | 15,464 |
| Repurchase AgreementRA | 1.01% | $725.72K | 725,723 |
| Regeneron Pharmaceuticals, Inc.REGN | 0.90% | $646.13K | 1,051 |
| HCA Healthcare, Inc.HCA | 0.86% | $617.78K | 1,632 |
| Cencora, Inc.COR | 0.76% | $546.53K | 2,029 |
| Edwards Lifesciences Corp.EW | 0.73% | $523.32K | 6,052 |
| Cardinal Health, Inc.CAH | 0.67% | $482.95K | 2,454 |
| IDEXX Laboratories, Inc.IDXX | 0.65% | $469.42K | 833 |
| Becton Dickinson & Co.BDX | 0.61% | $436.80K | 2,969 |
| Agilent Technologies, Inc.A | 0.55% | $399.68K | 2,949 |
| Waters Corp.WAT | 0.54% | $392.78K | 1,024 |
| Humana, Inc.HUM | 0.53% | $384.22K | 1,258 |
| Zoetis, Inc.ZTS | 0.47% | $341.99K | 4,402 |
| IQVIA Holdings, Inc.IQV | 0.45% | $322.15K | 1,768 |
| Biogen, Inc.BIIB | 0.42% | $299.88K | 1,530 |
| GE HealthCare Technologies, Inc.GEHC | 0.41% | $296.24K | 4,752 |
| DexCom, Inc.DXCM | 0.41% | $295.92K | 4,013 |
| Centene Corp.CNC | 0.40% | $290.31K | 4,871 |
| ResMed, Inc.RMD | 0.40% | $289.48K | 1,519 |
| N/ADerivative | 0.39% | $279.08K | 4,604 |
| Veeva Systems, Inc.VEEV | 0.38% | $274.93K | 1,577 |
| Mettler-Toledo International, Inc.MTD | 0.35% | $250.28K | 212 |
| West Pharmaceutical Services, Inc.WST | 0.34% | $242.11K | 750 |
| Labcorp Holdings, Inc.LH | 0.31% | $224.69K | 864 |
| Quest Diagnostics, Inc.DGX | 0.31% | $223.55K | 1,147 |
| STERIS plc | 0.30% | $217.62K | 1,023 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.